Brief: FDA Grants Priority Review For Abeona Therapeutics' Pz-cel Biologics License Application

Abeona Therapeutics

27/11/2023 13:59

Nov 27 (Reuters) - Abeona Therapeutics Inc  ABEO.O :
    * ABEONA THERAPEUTICS ANNOUNCES FDA ACCEPTS AND GRANTS
PRIORITY
REVIEW FOR PZ-CEL BIOLOGICS LICENSE APPLICATION (BLA)
    * ABEONA THERAPEUTICS INC - FDA DOES NOT CURRENTLY PLAN TO
HOLD
ADVISORY COMMITTEE MEETING FOR PZ-CEL BLA
    * ABEONA THERAPEUTICS INC - PDUFA TARGET ACTION DATE IS MAY
25,
2024

Source text for Eikon:  ID:nGNX7gz1Yq 
Further company coverage:  ABEO.O 

 ((Reuters.Briefs@thomsonreuters.com;))